DOAC-Remove™ 250
Ref. No. 5D-82410C

DOAC-Remove™ 250 tablets are intended to be used for removal of Direct Oral Anticoagulant (DOAC) compounds from human citrated plasma samples, including dabigatran, rivaroxaban, apixaban and edoxaban. Also removes argatroban. DOAC-Remove™ has no significant effect on clotting factors. Currently not for sale in US.

Size 250 tablets
Register to see prices
SKU: 5D-82410C Category:

Description

Removes DOACs and argatroban from citrated plasmas thereby reducing interference when the plasma is tested in laboratory coagulation assays such as APTT, TT, single factors, lupus AC, and APC-R.

DOAC-Remove™ is a CE marked product made to the exact specifications of 5-Diagnostics
For In Vitro Use Only.

 

Additional information

Size

250 tablets

Contact Switzerland

5-Diagnostics AG
Heuberg 7
CH-4051 Basel
Switzerland
+41 61 588 07 84
+41 61 588 07 86

Social Media

Newsletter

If you have any questions about our products or services, please feel free to contact us.
info@5-diagnostics.com